Drugs / Colon KCC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01722058 | Feb → Jun 2013 | colorectal neoplasm | University of Michigan | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Colon KCC | “The goal of this research is to develop the use of fluorescence-labeled peptides (Colon KCC) that affinity bind to pre-cancerous mucosa in the digestive tract for use as an...” NCT01722058 ↗ |
| Modality | Peptide | “Our peptide is a chain of 7 amino acids attached to a fluorescent dye called FITC” NCT01722058 ↗ |
| Route | Topical | “topically applied peptide” NCT01722058 ↗ |